Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |